CR

CRISM Therapeutics Corporation

Overview

Corporate Details

ISIN(s):
VGG042401262
LEI:
213800XFW6MKVCHHPW88
Country:
Virgin Islands (British)
Address:
C/O MAPLES FINANCE BVI LIMITED, VG1110 ROAD TOWN
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

No description available.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for CRISM Therapeutics Corporation. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 17:03
Post-Annual General Meeting Information
Result of AGM
English 25.8 KB
2025-08-26 08:00
Post-Annual General Meeting Information
AGM Statement
English 15.6 KB
2025-08-12 08:00
Regulatory News Service
GMP Manufacture of ChemoSeed
English 16.9 KB
2025-07-10 16:04
Major Shareholding Notification
Holding(s) in Company
English 23.3 KB
2025-07-03 08:00
Share Issue/Capital Change
Result of Retail Offer and Additional Placing
English 16.8 KB
2025-07-01 17:41
Capital/Financing Update
Update presentation on the IMC platform
English 14.9 KB
2025-06-30 08:01
Share Issue/Capital Change
Retail Offer
English 39.0 KB
2025-06-30 08:00
Share Issue/Capital Change
Placing
English 58.0 KB
2025-03-31 08:00
Legal Proceedings Report
Clinical Trial Update
English 17.3 KB
2025-03-27 08:00
Regulatory News Service
Innovate UK Grant Award
English 20.3 KB

Automate Your Workflow. Get a real-time feed of all CRISM Therapeutics Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CRISM Therapeutics Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Cantargia Logo
Develops antibody-based drugs targeting IL1RAP for cancer and inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Develops TPD drugs for oncology and autoimmune disorders, targeting 'undruggable' proteins.
Poland CTX
Developing engineered cellular medicines for regenerative treatment of heart failure.
United Kingdom N/A
Cellectis Logo
Biopharma using gene-editing to create off-the-shelf CAR T-cell cancer therapies.
France ALCLS
Celyad Oncology SA Logo
Clinical-stage biotech developing allogeneic & autologous CAR T-cell therapies for cancer.
Belgium CYAD
Cereno Scientific AB Logo
Clinical-stage biotech developing treatments for rare cardiovascular & pulmonary diseases.
Sweden CRNO
Ceres Power Holdings PLC Logo
Licensing solid oxide tech (SOFC/SOEC) for clean power and green hydrogen to global partners.
United Kingdom CWR
Cessatech A/S Logo
Develops non-invasive pain relief, like a nasal spray, for children.
Denmark CESSA
CHOSA Oncology AB Logo
Develops diagnostics and drug delivery for personalized cancer therapy.
Sweden CHOSA
Cinclus Pharma Holding AB Logo
Late-stage pharma developing a next-gen P-CAB drug for severe GERD and H. pylori.
Sweden CINPHA